Feasibility Study of adjuvant chemotherapy of S-1/Oxaliplatin for patients with Stage III gastric cancer patients - Feasibility Study of adjuvant chemotherapy of S-1/Oxaliplatin for patients with StageIII gastric cancer patients

Hamamatsu University School of Medicine0 个研究点目标入组 25 人开始时间: 2016年7月25日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)Active synchronous metachronous malignancy with longer than 5year interval period without below written cases Carcinoma in situ of cervical cancer and focal cancer in adenoma of colorectal cancer. 2)Contraindication of S-1 and Oxaliplatin 3)Regular use of flucytosine, phenytoin or warfarin potassium 4)Active infection with over 38 degree fever 5)History of serious drug hypersensitivity 6)Any other serious illness or medical conditions including interstitial paresis, intestinal obstruction, pneumonitis, pulmonary fibrosis, uncontrolled diabetes, renal failure, liver failure. 7)HIV positive or active hepatitis 8)Severe diarrhea (over 4 times/day or watery diarrhea) 9)Pregnancy or lactation 10)Male intension that get with child 11) Patients who are recognized as inadequate patients by doctor with responsibility in this study.

发起方